Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.

Dobrovolskaia MA, Patri AK, Potter TM, Rodriguez JC, Hall JB, McNeil SE.

Nanomedicine (Lond). 2012 Feb;7(2):245-56. doi: 10.2217/nnm.11.105. Epub 2011 Sep 30.

PMID:
21957862
2.

Biomedical applications of nano-antioxidant.

Watal G, Watal A, Rai PK, Rai DK, Sharma G, Sharma B.

Methods Mol Biol. 2013;1028:147-51. doi: 10.1007/978-1-62703-475-3_9. Review.

PMID:
23740118
3.

Dendrimers as versatile platform in drug delivery applications.

Svenson S.

Eur J Pharm Biopharm. 2009 Mar;71(3):445-62. doi: 10.1016/j.ejpb.2008.09.023. Epub 2008 Oct 17. Review.

PMID:
18976707
4.

Dendrimer nanocarriers as versatile vectors in gene delivery.

Dutta T, Jain NK, McMillan NA, Parekh HS.

Nanomedicine. 2010 Feb;6(1):25-34. doi: 10.1016/j.nano.2009.05.005. Epub 2009 May 18. Review. Retraction in: Nanomedicine. 2010 Dec;6(6):815.

PMID:
19450708
5.

PAMAM dendrimer roles in gene delivery methods and stem cell research.

Daneshvar N, Abdullah R, Shamsabadi FT, How CW, Mh MA, Mehrbod P.

Cell Biol Int. 2013 May;37(5):415-9. doi: 10.1002/cbin.10051. Epub 2013 Mar 18. Review.

PMID:
23504853
6.

Transepithelial and endothelial transport of poly (amidoamine) dendrimers.

Kitchens KM, El-Sayed ME, Ghandehari H.

Adv Drug Deliv Rev. 2005 Dec 14;57(15):2163-76. Epub 2005 Nov 11. Review.

PMID:
16289433
7.

Pharmaceutical and biomedical potential of surface engineered dendrimers.

Satija J, Gupta U, Jain NK.

Crit Rev Ther Drug Carrier Syst. 2007;24(3):257-306. Review.

PMID:
17956215
8.

The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles.

Fröhlich E.

Int J Nanomedicine. 2012;7:5577-91. doi: 10.2147/IJN.S36111. Epub 2012 Nov 2. Review.

Supplemental Content

Support Center